Prospective evaluation of KARSARC -a gene expression-based risk classifier for patients with soft tissue sarcomas treated with pazopanib
Research area:
Rare disease
Disease:
Intervention:
Phase:
Related news
Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments